CastleArk Management »

Cogent Biosciences shares owned by CastleArk Management

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by CastleArk Management from 13F filings

Historical chart of CastleArk Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by CastleArk Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by CastleArk Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 64k 38.49

More positions owned by CastleArk Management

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (SPIB)
Apple (AAPL)
Ishares Tr Us Treas Bd Etf (GOVT)
Lam Research Corp Com New (LRCX)
Meta Platforms Cl A (META)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Amazon (AMZN)
Gilead Sciences (GILD)
Charles Schwab Corporation (SCHW)

View all positions for CastleArk Management

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Group
Deerfield Management Company
Rtw Investments
Vanguard Portfolio Management
Vanguard Capital Management
Henderson Group
Fairmount Funds Management
TCG Crossover Management
State Street Corporation
Goldman Sachs Group
Kynam Capital Management
Geode Capital Management
Lord, Abbett & Co

View all funds holding Cogent Biosciences